title: Wernicke's Encephalopathy in an Acute Myeloid Leukemia Patient: A Case Study.
authors.affiliation: Trakya University Faculty of Medicine, Department of Hematology, Edirne, Turkey. E-mail: drmaden@yandex.com.
authors.forename: Muhammet
authors.initials: M
authors.lastname: Maden
authors.forename: Gülsüm
authors.initials: G
authors.lastname: Pamuk
authors.forename: Yahya
authors.initials: Y
authors.lastname: Çelik
authors.forename: Ercüment
authors.initials: E
authors.lastname: Ünlü
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage / Q000009:adverse effects; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy; D013831:Thiamine / Q000627:therapeutic use; D014740:Vidarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D014899:Wernicke Encephalopathy / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*
chemical_list: D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D014740:Vidarabine; D013831:Thiamine; D015255:Idarubicin